Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M32,495Revenue (TTM) $M7,956Net Margin (%)-4.3Altman Z-Score1.3
Enterprise Value $M37,484EPS (TTM) $-0.3Operating Margin %-7.7Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-11.0Higher ROA y-yN
Price/Book5.210-y EBITDA Growth Rate %--Quick Ratio0.7Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %--Current Ratio1.1Lower Leverage y-yY
Price/Free Cash Flow32.9y-y EBITDA Growth Rate %-150.3ROA % (ttm)-1.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-5.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,361ROIC % (ttm)-1.7Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMichael Price 2016-06-30 Reduce-2.22%$18.81 - $23.37
($21.59)
$ 23.8811%Reduce -48.28%900,000
BSXVanguard Health Care Fund 2016-06-30 Reduce-0.4%$18.81 - $23.37
($21.59)
$ 23.8811%Reduce -15.19%53,619,190
BSXMario Gabelli 2016-06-30 Reduce-0.01%$18.81 - $23.37
($21.59)
$ 23.8811%Reduce -13.60%687,746
BSXJohn Paulson 2016-06-30 Add$18.81 - $23.37
($21.59)
$ 23.8811%Add 27.03%94,000
BSXDodge & Cox 2016-06-30 Reduce$18.81 - $23.37
($21.59)
$ 23.8811%Reduce -9.94%384,930
BSXMichael Price 2016-03-31 Reduce-0.55%$16.07 - $18.82
($17.57)
$ 23.8836%Reduce -12.12%1,740,000
BSXVanguard Health Care Fund 2016-03-31 Reduce-0.03%$16.07 - $18.82
($17.57)
$ 23.8836%Reduce -1.38%63,222,390
BSXJohn Paulson 2016-03-31 Buy 0.01%$16.07 - $18.82
($17.57)
$ 23.8836%New holding74,000
BSXDodge & Cox 2016-03-31 Reduce$16.07 - $18.82
($17.57)
$ 23.8836%Reduce -5.19%427,430
BSXMario Gabelli 2016-03-31 Reduce$16.07 - $18.82
($17.57)
$ 23.8836%Reduce -3.13%796,046
BSXDodge & Cox 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 23.8833%Reduce -4.68%450,830
BSXMario Gabelli 2015-12-31 Reduce$16.42 - $18.94
($17.96)
$ 23.8833%Reduce -2.96%821,746
BSXVanguard Health Care Fund 2015-09-30 Add0.16%$15.78 - $18.02
($17.1)
$ 23.8840%Add 7.52%64,108,690
BSXMario Gabelli 2015-09-30 Reduce-0.01%$15.78 - $18.02
($17.1)
$ 23.8840%Reduce -12.09%846,846
BSXDodge & Cox 2015-09-30 Reduce$15.78 - $18.02
($17.1)
$ 23.8840%Reduce -19.60%472,960
BSXMario Gabelli 2015-06-30 Reduce-0.03%$17.18 - $18.51
($17.87)
$ 23.8834%Reduce -26.90%963,296
BSXDodge & Cox 2015-06-30 Reduce$17.18 - $18.51
($17.87)
$ 23.8834%Reduce -19.36%588,260
BSXMario Gabelli 2015-03-31 Reduce-0.02%$13.22 - $18.07
($15.8)
$ 23.8851%Reduce -20.16%1,317,796
BSXDodge & Cox 2015-03-31 Reduce-0.01%$13.22 - $18.07
($15.8)
$ 23.8851%Reduce -38.43%729,460
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 23.8887%Reduce -97.34%1,184,730
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sorenson John BradleySVP, Manuf & Sup Chn 2016-08-11Sell2,500$23.90.88view
Mahoney Michael FPresident & CEO 2016-08-01Sell44,400$24.44-1.35view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-08-01Sell24,000$24.46-1.43view
Pierce David ASVP and President, Endoscopy 2016-07-20Sell2,480$24.030.33view
Phalen Michael P.EVP & President, MedSurg 2016-07-20Sell35,000$24.030.33view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2016-07-20Sell78,122$24.030.33view
Pratt Timothy A.EVP, GC & Chief Admin Officer 2016-06-01Sell24,229$22.666.4view
Mahoney Michael FPresident & CEO 2016-06-01Sell100,000$22.696.26view
Sorenson John BradleySVP, Manuf & Sup Chn 2016-05-11Sell2,800$22.158.85view
Dawkins Keith DEVP, Global Chief Med. Off. 2016-05-10Sell80,000$22.158.85view

Press Releases about BSX :

Quarterly/Annual Reports about BSX:

News about BSX:

Articles On GuruFocus.com
Michael Price Trims Boston Scientific, Buys Outerwall Aug 23 2016 
Eaton Vance Worldwide Health Sciences Fund 2nd Quarter Commentary Aug 04 2016 
Vanguard Sold Shares in 7 of Top 10 Quarterly Transactions Aug 02 2016 
Sam Isaly's Top Investments of the Year Aug 01 2016 
Johnson & Johnson Reports 4% Sales Growth for the Second Quarter Jul 22 2016 
Weekly CEO Sells Highlight: Gilead Sciences, Boston Scientific, Sonic, HealthEquity Apr 10 2016 
Weekly CEO Sells Highlight: Motorcar Parts of America, The Interpublic Group of Companies, Gilead Sc Mar 07 2016 
The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings Nov 04 2015 
Third Point's Third Quarter Letter Nov 02 2015 
Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 

More From Other Websites
Analysts’ Latest Recommendations for Boston Scientific Aug 23 2016
Delving into BSX’s Category Leadership Growth Strategy Aug 22 2016
Zacks.com featured highlights: Macy's, Discovery Communications, Zoetis, Boston Scientific and... Aug 22 2016
What’s BSX’s Capital Allocation Strategy Going Forward? Aug 22 2016
Edwards Lifesciences Is Taking The Surgery Out Of Heart Surgery Aug 22 2016
Discussing Boston Scientific’s Expanding Operating Margins Aug 19 2016
What’s Driving Boston Scientific’s Rhythm Management Segment? Aug 19 2016
5 Top ROE Stocks to Play in an Aging Bull Market Aug 19 2016
How BSX Plans to Accelerate Its Neuromodulation Market Position Aug 18 2016
A Look at Boston Scientific’s Latest Valuation Aug 18 2016
FDA Approves Boston Scientific's Emblem MRI S-ICD System Aug 15 2016
BOSTON SCIENTIFIC CORP Financials Aug 10 2016
Boston Scientific Adds EMBLEM MRI S-ICD System To Its Growing ImageReady MR-Conditional Devices Aug 09 2016
Boston Scientific Announces U.S. FDA Approval Of EMBLEM™ MRI S-ICD System Aug 09 2016
Boston Scientific Announces U.S. FDA Approval Of EMBLEM™ MRI S-ICD System Aug 09 2016
[$$] Medicare Requires Some Heart Patients to See a Second Doctor Aug 08 2016
ETF’s with exposure to Boston Scientific Corp. : August 4, 2016 Aug 04 2016
Zacks.com featured highlights: Macy's, General Mills, Zoetis, Boston Scientific and Citrix Systems Aug 04 2016
BOSTON SCIENTIFIC CORP Files SEC form 10-Q, Quarterly Report Aug 03 2016
5 Top ROE Stocks to Buy as Earnings Growth Remains Elusive Aug 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)